{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:52:49Z","timestamp":1762865569896,"version":"3.37.0"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To study the influence of media attention about statins and ADRs on the level of disproportionality, expressed as the reporting odds ratio (ROR) for statins in the Lareb database, based on patients' reports.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patient reports about statins, before and after the broadcast of a consumer programme about statins, were compared. In order to calculate the correlation between the ROR for patient\u2010statin reports between the period before and after the broadcast a Pearson correlation\u2010coefficient (r) was calculated. The type of reported ADRs associated with statins before and after the broadcast was compared both on the level of system organ class (SOC) and preferred terms (PT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Pearson's Correlation\u2010coefficient for the comparison of RORs before and after the broadcast was 0.83. In respect to specific ADRs, no differences were found in reporting on SOC level before and after the broadcast, except for the SOC<jats:italic>Musculoskeletal and connective tissue disorders<\/jats:italic>. For ADRs that were specifically mentioned during the broadcast, no differences were found except for an increased number of myalgia and arthralgia reports.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study demonstrates that media attention does not necessarily influence the relative reporting by patients expressed as RORs in the national ADR database. On SOC level only in<jats:italic>Musculoskeletal and connective tissue disorders<\/jats:italic>the relative reporting increased. For myalgia and arthralgia, there was a proportional increase of reporting within the statin class but not for the other ADRs that were explicitly mentioned in the TV programme about statins. Copyright \u00a9 2009 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.1865","type":"journal-article","created":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T11:19:02Z","timestamp":1259666342000},"page":"26-32","source":"Crossref","is-referenced-by-count":25,"title":["Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins"],"prefix":"10.1002","volume":"19","author":[{"given":"Florence","family":"van Hunsel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eug\u00e8ne","family":"van Puijenbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lolkje","family":"de Jong\u2010 van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kees","family":"van Grootheest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_1_2_2","DOI":"10.1007\/s00228-008-0475-9"},{"doi-asserted-by":"publisher","key":"e_1_2_1_3_2","DOI":"10.2165\/00002018-200730100-00007"},{"doi-asserted-by":"publisher","key":"e_1_2_1_4_2","DOI":"10.2165\/00002018-200831060-00006"},{"issue":"10","key":"e_1_2_1_5_2","first-page":"529","article-title":"Direct reporting of side effects by the patient: favourable experience in the first year","volume":"149","author":"van Grootheest AC","year":"2005","journal-title":"Ned Tijdschr Geneeskd"},{"doi-asserted-by":"publisher","key":"e_1_2_1_6_2","DOI":"10.2165\/00002018-200831070-00006"},{"doi-asserted-by":"publisher","key":"e_1_2_1_7_2","DOI":"10.1046\/j.1365-2125.2002.01569.x"},{"doi-asserted-by":"publisher","key":"e_1_2_1_8_2","DOI":"10.1111\/j.1365-2125.2005.02528.x"},{"issue":"3","key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JRS-2002-286","article-title":"Paroxetine, Panorama and user reporting of ADRs: consumer intelligence matters in clinical practice and post\u2010marketing drug surveillance","volume":"15","author":"Medawar C","year":"2002","journal-title":"Int J Risk Saf Med"},{"doi-asserted-by":"crossref","unstructured":"MartinRM MayM GunnellD.Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases 2001\u20132004.Br J Clin Pharmacol2006;61(2):224\u2013228.","key":"e_1_2_1_10_2","DOI":"10.1111\/j.1365-2125.2005.02527.x"},{"doi-asserted-by":"publisher","key":"e_1_2_1_11_2","DOI":"10.1136\/bmj.39157.755718.DB"},{"unstructured":"Stichting KijkOnderzoek. (SKO Dutch Audience Research Foundation). Analysis TV Programme Radar. Accessed on 13 May 2009. Ref Type: Data File.","key":"e_1_2_1_12_2"},{"unstructured":"The Dutch Cardiology Society (NVVC).Tros Radar and cholesterol lowering drugs2007.http:\/\/www.nvvc.nl\/UserFiles\/0039.07%20Radar%20Statines1.pdf. Accessed on 15 May 2009. Ref Type: Electronic Citation.","key":"e_1_2_1_13_2"},{"unstructured":"WHO Collaborating Centre for Drug Statistics Methodology.The ATC\/DDD system.http:\/\/www.whocc.no\/atcddd\/2008. Accessed on 15 May 2009. Ref Type: Electronic Citation.","key":"e_1_2_1_14_2"},{"doi-asserted-by":"publisher","key":"e_1_2_1_15_2","DOI":"10.2165\/00002018-200225060-00009"},{"doi-asserted-by":"publisher","key":"e_1_2_1_16_2","DOI":"10.2165\/00002018-199920020-00002"},{"unstructured":"International Conference on Harmonisation (ICH).MedDRA\u00ae Term Selection: Points To Consider.http:\/\/www.meddramsso.com\/MSSOWeb\/document_library\/TermSelPTC_R3.8.pdf. 2\u20104\u20102007. Accessed on 18 April 2009. Ref Type: Internet Communication.","key":"e_1_2_1_17_2"},{"unstructured":"CIOMS Working Group IV.Benefit\u2010risk balance for marketed drugs: evaluating safety signals.1998. Geneva. Ref Type: Report.","key":"e_1_2_1_18_2"},{"doi-asserted-by":"publisher","key":"e_1_2_1_19_2","DOI":"10.1136\/bmj.328.7441.702"},{"doi-asserted-by":"publisher","key":"e_1_2_1_20_2","DOI":"10.1002\/sim.1157"},{"doi-asserted-by":"publisher","key":"e_1_2_1_21_2","DOI":"10.1111\/j.1365-2125.2009.03400.x"},{"issue":"6","key":"e_1_2_1_22_2","first-page":"297","article-title":"Differences between men and women in the use of statins","volume":"46","author":"Van Dijk L","year":"2003","journal-title":"Huisarts & Wetenschap"},{"doi-asserted-by":"publisher","key":"e_1_2_1_23_2","DOI":"10.1023\/B:PHAR.0000006518.22231.ea"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1865","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1865","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.1865","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T14:53:15Z","timestamp":1739458395000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1002\/pds.1865"],"URL":"https:\/\/doi.org\/10.1002\/pds.1865","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"type":"print","value":"1053-8569"},{"type":"electronic","value":"1099-1557"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}